Company / Current Liabilities per Share
Moleculin Biotech, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$50.71
FY2025
5-year range
$0.31 / $50.71
FY2021-FY2025
Trend
+2007.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +2008% YoY in FY2025, a notable deviation from the 8-year average annual change of +395%.
Based on SEC 10-K filings.
50.71 in FY2025 with a 5-year CAGR of +165.7%.
Increased from $3.57 to $50.71 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +165.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 2007.9% year-over-year.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.71 | +2007.9% |
| FY2024 | $2.41 | -32.6% |
| FY2023 | $3.57 | - |
| FY2022 | - | - |
| FY2021 | $0.31 | -18.1% |
| FY2020 | $0.38 | +206.2% |
| FY2019 | $0.13 | -30.7% |
| FY2018 | $0.18 | -0.8% |
| FY2017 | $0.18 | -9.8% |
| FY2016 | $0.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026